Radiation 'Priming' tested to supercharge cancer immunotherapy
NCT ID NCT03313804
Summary
This study tested if a short, targeted dose of radiation given right before starting standard immunotherapy could improve results for people with advanced lung or head/neck cancer. The idea was that radiation might release cancer markers to help the immune drugs work better. Researchers enrolled 76 patients to see if this combination helped control cancer growth for longer compared to past treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky Markey Cancer Center
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.